Rationale and Design of Therapeutic Angiogenesis by Cell Transplantation Using Adipose-Derived Regenerative Cells in Patients With Critical Limb Ischemia　― TACT-ADRC Multicenter Trial ―-Reference-Cited by-同舟云学术

Rationale and Design of Therapeutic Angiogenesis by Cell Transplantation Using Adipose-Derived Regenerative Cells in Patients With Critical Limb Ischemia　― TACT-ADRC Multicenter Trial ―

Published:2020-09-10 Issue:9 Volume:2 Page:531-535
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Shimizu Yuuki¹,Kondo Kazuhisa¹,Fukumoto Yoshihiro²,Takamura Masayuki³,Inoue Teruo⁴,Nagata Tokuichiro⁵,Akashi Yoshihiro J.⁶,Yamada Yoshihiro⁷,Kuwahara Koichiro⁸,Kobayashi Yoshio⁹,Shibata Rei¹⁰,Murohara Toyoaki¹,

Affiliation:

1. Department of Cardiology, Nagoya University Graduate School of Medicine

2. Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine

3. Department of Cardiology, Graduate School of Medical Science, Kanazawa University

4. Department of Cardiovascular Medicine, Dokkyo Medical University

5. Department of Cardiovascular Surgery, St. Marianna University School of Medicine

6. Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine

7. Department of Cardiovascular Medicine, Fukuoka Tokushukai Medical Center

8. Department of Cardiovascular Medicine, Shinshu University School of Medicine

9. Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine

10. Department of Advanced Cardiovascular Therapeutics, Nagoya University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/2/9/2_CR-20-0055/_pdf

Reference26 articles.

1. 1. Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. and Group ESCSD. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 2018; 39: 763–816.

2. 2. Beckman JA, Duncan MS, Damrauer SM, Wells QS, Barnett JV, Wasserman DH, et al. Microvascular disease, peripheral artery disease, and amputation. Circulation 2019; 140: 449–458.

3. 3. Bevan GH, White Solaru KT. Evidence-based medical management of peripheral artery disease. Arterioscler Thromb Vasc Biol 2020; 40: 541–553.

4. 4. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. Circulation 2017; 135: e726–e779.

5. 5. Miyahara T, Suhara M, Nemoto Y, Shirasu T, Haga M, Mochizuki Y, et al. Long-term results of treatment for critical limb ischemia. Ann Vasc Dis 2015; 8: 192–197.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial;Angiogenesis;2022-07-08

2. Adipose-derived regenerative cells as a promising therapy for cardiovascular diseases: an overview;NAGOYA J MED SCI;2022

3. Future of Therapeutic Angiogenesis Using Adipose-Derived Stem Cells in the Cardiovascular Field;Circulation Journal;2021-04-23

4. No influence on tumor growth by intramuscular injection of adipose-derived regenerative cells: safety evaluation of therapeutic angiogenesis with cell therapy;American Journal of Physiology-Heart and Circulatory Physiology;2021-01-01